02417nam 2200577 a 450 991013963130332120170815153718.01-283-17566-597866131756631-118-02366-81-118-02367-61-118-02365-X(CKB)2550000000041121(EBL)693249(OCoLC)745970855(SSID)ssj0000524794(PQKBManifestationID)12222185(PQKBTitleCode)TC0000524794(PQKBWorkID)10488185(PQKB)11413967(MiAaPQ)EBC693249(PPN)243334850(EXLCZ)99255000000004112120101020d2011 uy 0engur|n|---|||||txtccrPharmaceutical anti-counterfeiting[electronic resource] combating the real danger from fake drugs /Mark DavisonHoboken, N.J. John Wiley & Sonsc20111 online resource (428 p.)Description based upon print version of record.0-470-61617-2 Includes bibliographical references and index.pt. 1. General themes -- pt. 2. Authentication -- pt. 3. Product tracking -- pt. 4. Conclusions and the future -- pt. 5. Further Resources.This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation,Product counterfeitingDrug adulterationProduct counterfeiting.Drug adulteration.615.1068/4615.10684Davison Mark1968 Mar. 1-983906MiAaPQMiAaPQMiAaPQBOOK9910139631303321Pharmaceutical anti-counterfeiting2246383UNINA